The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic.
The coronavirus disease (COVID-19) is the global public health challenge currently persisting at a grand scale. A method that meets the rapid quantitative detection of antibodies to assess the body's immune response from natural COVID-19 illness or vaccines' effects is urgently needed. In...
|Main Authors:||, , , , , , ,|
Public Library of Science (PLoS)